Brief by Shorts91 Newsdesk / 02:39pm on 09 May 2024,Thursday Health & Wellness
In a groundbreaking development, 18-month-old Opal Sandy from Oxfordshire hears almost perfectly after receiving pioneering gene therapy for auditory neuropathy. The procedure, which took just 16 minutes, marks a new era in treating deafness. Doctors at Addenbrooke’s hospital, Cambridge, are running the Chord trial, recruiting deaf children from the UK, Spain, and the US. Prof. Manohar Bance, the trial's chief investigator, expresses optimism, stating the results are better than expected. The therapy, using a working copy of the OTOF gene, is a potential cure. Opal is the first patient globally to undergo this treatment, offering hope for others.
